Par Pharmaceutical, headquartered in Chestnut Ridge, NY, is an operating company of Endo International plc. Par develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical and branded injectable products that help improve patient quality of life. Par, among the top leaders in the U.S. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a robust research and development (R&D) pipeline of potential products. The Par facilities located in India support our U.S. business in key areas, such as manufacturing and R&D.
Company Details
- Employees
- 19
- Address
- Mumbai, In
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- & Validation at Par Pharmaceuticals.
- HQ
- Mumbai
Par India Questions
Par India's website is https://www.parpharm.com/about/india-facilities.php
Par India's LinkedIn profile is https://in.linkedin.com/company/par-india
Par India has
19 employees.
View email and phone details for 19
employees at Par India.
Par India's industry is
Pharmaceutical Manufacturing
Par India's top competitors are
Gsk,
Piramal Pharma Ltd,
Endo,
Endo Pharmaceuticals,
Par Pharmaceutical,
Softgel Healthcare Private Limited,
Sun Pharma,
Cipla,
Glenmark Pharmaceuticals,
Teva Pharmaceuticals.
Par India's categories are Pharmaceutical Manufacturing
